Epidermal growth factor receptor and variant III targeted immunotherapy

Immunotherapeutic approaches to cancer have shown remarkable promise. A critical barrier to successfully executing such immune-mediated interventions is the selection of safe yet immunogenic targets. As patient deaths have occurred when tumor-associated antigens shared by normal tissue have been tar...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Congdon, Kendra L., Gedeon, Patrick C., Suryadevara, Carter M., Caruso, Hillary G., Cooper, Laurence J.N., Heimberger, Amy B., Sampson, John H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2014
Pynciau:
Invited Reviews
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4207138/
https://ncbi.nlm.nih.gov/pubmed/25342601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou236
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg